Maria Julia Montoro, MD PhD^1*, Margarita Ortega, PhD^1*, Guillermo Villacampa^2*, Teresa Bernal, MD, PhD^3*, Helena Pomares, MD PhD^4*, Elvira Mora Casterá, MD^5*, Antonieta Molero, MD^6*, Laura Vilorio, MD^7*, Mar Tormo, MD⁸, Marina Diaz-Beyá, MD^9*, Merchan Brayan, MD^10*, Andres Jerez, MD PhD^11*, Eugenia Rivero, MD^12*, Maria Jose Lys, MD^13*, Paula Cárcel, MD^14*, Joan Bargay, MD^15*, Fernando Ramos^16*, Blanca Xicoy, MD^17*, Maria Diez-Campelo, PhD, MD^18* and David Valcarcel¹⁹

¹Department of Hematology, Vall d’Hebron Hospital Universitari, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain
²Oncology Data Science (ODysSey) Group, Vall d´Hebron Institute of Oncology, Barcelona, Spain
³Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain
⁴Clinical Hematology Department, Institut Català d'Oncologia, Hospital Duran i Reynals, IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain, L’Hospitalet de Llobregat, Barcelona, Spain
⁵Department of Hematology Hospital Universitario y Politécnico La Fe. Instituto de Investigación Sanitaria La Fe, Valencia, Spain
⁶1. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Departament de Medicina, Universitat Autònoma de Barcelona,, Barcelona, Spain
⁷Department of Hematology, University Hospital Central of Asturias, Oviedo, Spain
⁸Department of Hematology, University Hospital Clínico of Valencia, Valencia, Spain
⁹Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain
¹⁰Hospital del Mar, Barcelona, Spain
¹¹Hematology and Medical Oncology Department, Hospital Morales Meseguer, IMIB, Murcia, Spain, MURCIA, Spain
¹²Department of Hematology, University Hospital Arnau de Vilanova, Lleida, Spain
¹³Department of Hematology, Consorcio Hospital General Universitario de Valencia, Valencia, Spain
¹⁴Department of Hematology, Hospital Público Universitario de la Ribera, Alzira, Valencia, Spain
¹⁵Department of Hematology, Son Llatzer University Hospital/ IdISBa, Palma de Mallorca, Spain
¹⁶Department of Hematology, Complejo Asistencial Universitario de León, León, Spain
¹⁷Hematology Department, Institut Català d'Oncologia-Hospital Germans Trias i Pujol; Josep Carreras Leukemia Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain
¹⁸Hematology Department, Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, Salamanca, Spain
¹⁹Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Hospital Universitari, Barcelona, Spain

Amer M. Zeidan, MBBS, MHS¹, Daniel A. Pollyea, MD², Jacqueline S. Garcia³, Andrew M. Brunner^4*, Fernando Roncolato^5*, Uma Borate⁶, Olatoyosi Odenike, MD⁷, Ashish Bajel, FRACP⁸, Anne-Marie Watson^9*, Katharina S. Götze¹⁰, Florian Nolte, MD^11*, Peter Tan, MBBS^12*, Haifa K Al-Ali^13*, Wan-Jen Hong, MD¹⁴, Ying Zhou, PhD^15*, Martin Dunbar^16*, Lori Gressick^16*, William Ainsworth¹⁷, Jason Harb, PhD^17*, Relja Popovic¹⁶, Ahmed H Salem¹⁶, John Hayslip^16*, Ronan Swords¹⁶ and Guillermo Garcia-Manero, MD¹⁸

¹Section of Hematology, Department of Internal Medicine, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
²UCHealth University of Colorado Hospital, Denver, CO
³Department of Medicine, Dana Farber Cancer Institute, Boston, MA
⁴Center for Leukemia, Massachusetts General Hospital, Boston, MA
⁵Department of Hematology, University of New South Wales, Sydney, NSW, Australia
⁶Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, OR
⁷University of Chicago Medicine and Comprehensive Cancer Center, Chicago, IL
⁸Haematology Department, Royal Melbourne Hospital, Parkville, Australia
⁹Department of Haematology, Liverpool Hospital, Liverpool, AUS
¹⁰Department of Medicine III, Technical University of Munich, Munich, Germany
¹¹Department of Hematology and Oncology, Medical Faculty Mannheim of the Heidelberg University, Mannheim, Germany
¹²Department of Haematology Cell and Tissue Therapies, Royal Perth Hospital, Perth, Australia
¹³Department of Hematology and Medical Oncology, University Hospital of Halle, Halle, Germany
¹⁴Genentech, Inc., South San Francisco, CA
¹⁵AbbVie Inc., North Chicago, IL
¹⁶AbbVie Inc, North Chicago, IL
¹⁷AbbVie, Inc., North Chicago, IL
¹⁸Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Carolien Duetz, MD^1*, Sofie Van Gassen, PhD^2,3*, Theresia M. Westers, PhD^1*, Florentien in t Hout, MD PhD^4*, Eline Cremers, MD PhD^1*, Canan Alhan, MD, PhD^1*, Costa Bachas, PhD^1*, Margot F. Van Spronsen, MD^1*, Heleen Visser-Wisselaar^5*, Dana Chitu^5*, Aniek O. De Graaf, PhD^4*, Joop Jansen, PhD⁴, Yvan Saeys, PhD^2,3* and Arjan van de Loosdrecht, MD, PhD^1*

¹Department of Hematology, Amsterdam University Medical Center, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, Netherlands
²VIB Inflammation Research Center, Ghent University, Ghent, Belgium., Ghent, Belgium
³Department of Applied Mathematics, Computer Science and Statistics, Ghent University, Ghent, Belgium., Ghent, Belgium
⁴Laboratory of Hematology, Radboud University Medical Centre, Nijmegen, The Netherlands., Nijmegen, Netherlands
⁵HOVON Data Center, Erasmus MC Cancer Institute, Department of Hematology, Rotterdam, Netherlands

Rami S. Komrokji, MD¹, Uwe Platzbecker, MD², Pierre Fenaux, MD, PhD³, Guillermo Garcia-Manero, MD⁴, Ghulam J. Mufti, Professor^5*, Valeria Santini^6*, Maria Diez-Campelo, PhD, MD^7*, Carlo Finelli^8*, Joseph G. Jurcic, MD⁹, Peter L. Greenberg¹⁰, Mikkael A. Sekeres¹¹, Amer M. Zeidan, MBBS, MHS¹², Amy E. DeZern, MD¹³, Michael R. Savona, MD¹⁴, Jeevan K. Shetty^15*, Rodrigo Ito^16*, George Zhang^16*, Xianwei Ha^16*, Daniel Sinsimer^16*, Jay T. Backstrom^17* and Amit Verma, MBBS¹⁸

¹Moffitt Cancer Center, Tampa, FL
²Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
³Service d’Hématologie Séniors, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris and Université Paris 7, Paris, France
⁴Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁵Department of Haemato-Oncology, King's College London, London, United Kingdom
⁶MDS Unit, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, FI, Italy
⁷Hematology Department, Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, Salamanca, Spain
⁸Department of Oncology and Hematology, S. Orsola-Malpighi University Hospital, Bologna, Italy
⁹Division of Hematology/Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
¹⁰Stanford University Cancer Institute, Stanford, CA
¹¹Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
¹²Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT
¹³The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
¹⁴Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN
¹⁵Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland
¹⁶Bristol Myers Squibb, Princeton, NJ
¹⁷Acceleron Pharma, Cambridge, MA
¹⁸Hematology/Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY

Florence Rabian, MD^1,2*, Jérôme Lambert^3,4*, Daniela Barbieri^5*, Berengere Gruson, MD^6*, Sylvain Thepot, MD^7*, Thorsten Braun, MD, PhD^8,9, Norbert Vey, MD¹⁰, Jacques Delaunay, MD^11*, Laurence Legros, PhD, MD^12*, Julie Lejeune^13*, Anouk Walter-petrich^14*, Rosa Sapena^15*, Nathalie Droin, PhD^16,17*, Fatiha Chermat^18*, Francoise Porteu^19*, Daniel Lusina^20*, Lionel Ades, MD, PhD²¹, Eric Solary, MD, PhD²², Pierre Fenaux, MD, PhD^23* and Raphael Itzykson, MD, PhD^24,25,26

¹University of Paris, Paris, France
²Adolescent and Young Adult Hematology Unit, Saint Louis Hospital, Paris, France
³Biostatistical Department, Hôpital Saint Louis, Paris, France
⁴Inserm U1153, Paris, FRA
⁵UMR 1170, Gustave Roussy Institute, Villejuif, France
⁶Hematology department, CHU Amiens, Amiens, France
⁷Clinical Hematology, Angers University Hospital, Angers, France
⁸IUH, EA3518 Leukemia Translational Laboratory, Paris, France
⁹Hematology, Avicenne Hospital, Bobigny, France
¹⁰Paoli-Calmette Cancer Institute, Marseille, France
¹¹Clinical Hematology, Institut de Cancérologie Catherine de Sienne, Nantes, France
¹²Department of Hematology, Centre Hospitalier Universitaire de Nice, Nice, WA
¹³Biostatistics Department, Hopital Saint-Louis, Assistance Publique Hopitaux de Paris, Paris Diderot University, Paris, France
¹⁴SBIM, Hospital Saint Louis, Paris, France
¹⁵Groupe Francophone des Myélodysplasies, Paris, France
¹⁶Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France
¹⁷INSERM U1170, Villejuif, France, France
¹⁸Service d'Hématologie Séniors, Hôpital Saint-Louis, Paris, France
¹⁹UMR 1170, Institut Gustave Roussy, Villejuif, France
²⁰Laboratory of Hematology, Avicenne Hospital, APHP, University Paris XIII, Bobigny, France
²¹Institut Univeristaire d'Hematologie, Hopital Saint Louis, Paris, France
²²INSERM U1170, Université Paris-Sud, Gustave Roussy Cancer Center, Villejuif, France
²³Hématologie Clinique Senior, Hôpital Saint-Louis, Paris, France
²⁴Laboratoire de Transfert des Leucémies, Institut Universitaire d'Hématologie, University Paris VII, Paris, France
²⁵Hematology Department, Saint-Louis Hospital AP-HP Paris France, Paris, France
²⁶INSERM U944, Institute of Hematology, Saint-Louis Hospital, Paris, France

Uwe Platzbecker, MD¹, Pierre Fenaux, MD, PhD², David P. Steensma, MD³, Koen Van Eygen, MD^4*, Azra Raza, MD⁵, Ulrich Germing^6*, Patricia Font, MD^7*, Maria Diez-Campelo, PhD, MD^8*, Sylvain Thepot, MD^9*, Edo Vellenga, MD, PhD¹⁰, Mrinal M. Patnaik, MD, MBBS¹¹, Jun Ho Jang, MD, PhD¹², Laurie Sherman, BSN¹³, Souria Dougherty, BS, MBA^13*, Libo Sun, PhD^13*, Fei Huang, PhD^13*, Ying Wan, PhD^13*, Aleksandra Rizo, MD, PhD¹³, Tymara Berry, MD^13*, Faye Feller, MD¹³ and Valeria Santini¹⁴

¹Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
²Hôpital Saint-Louis, Université Paris Diderot, Paris, France
³Dana-Farber Cancer Institute, Boston, MA
⁴Algemeen Ziekenhuis Groeninge, Kortrijk, Belgium
⁵Columbia University Medical Center, New York, NY
⁶Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Faculty of Medicine, Düsseldorf, Germany
⁷Department of Hematology, Hospital General Universitario Gregorio Marañon, Madrid, Spain
⁸Grupo Español de Síndromes Mielodisplásicos (GESMD), Valencia, Spain
⁹Service des Maladies du Sang, CHU Angers, Angers, France
¹⁰Department of Hematology, University Medical Center Groningen, Groningen, Netherlands
¹¹Division of Hematology, Mayo Clinic, Rochester, MN
¹²Department of Hematology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
¹³Geron Corporation, Parsippany, NJ
¹⁴MDS Unit- Hematology, AOU Careggi-University of Florence, Firenze, Fi, Italy

Jonathan Feld, MD, Erin P. Demakos, RN^*, Rosalie Odchimar-Reissig, RN^*, Douglas Tremblay, MD, Saudia Alli, NP^*, Darshanie Sewah, RN^*, Shyamala C. Navada, MD and Lewis R. Silverman, MD

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

Zhongxun Shi, MD^1*, Bing Li, MD^1*, Tiejun Qin, MD^1*, Zefeng Xu, MD^1*, Lijuan Pan, MD^1*, Shiqiang Qu, MD^1*, Gang Huang, PhD² and Zhijian Xiao, MD^3*

¹Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
²Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Guillermo Montalban Bravo, MD¹, Rashmi Kanagal-Shamanna, MD², Faezeh Darbaniyan, PhD^3*, Irene Ganan-Gomez, PhD¹, Koji Sasaki, MD⁴, Kiran Naqvi, MD, MPH⁴, Yue Wei, PhD¹, Hui Yang, MD, PhD¹, Kelly A. Soltysiak, PhD^4*, Kelly S. Chien, MD¹, Carlos E. Bueso-Ramos, MD, PhD², Hagop M. Kantarjian, MD¹ and Guillermo Garcia-Manero, MD⁴

¹Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Michael A Spinner, MD¹, Steven A Schaffert, PhD^2*, Alexey Aleshin, MD, MBA³, Marianne T Santaguida, PhD^2*, Hiroomi Tada, MD PhD² and Peter L. Greenberg³

¹Division of Oncology, Department of Medicine, Stanford University, Stanford, CA
²Notable Labs, Foster City, CA
³Division of Hematology, Department of Medicine, Stanford University, Stanford, CA

Ifeyinwa Emmanuela Obiorah, MBBS, PhD¹, David B. Beck, MD, PhD^2*, Weixin Wang, Ph.D.^3*, Amanda Ombrello, MD^4,5*, Marcela A Ferrada, MD^6*, Zhijie Wu, MD^7*, Keith A Sikora, MD^8*, Megan A Trick^8*, Alina Dulau-Florea, MD^9*, Bhavisha A Patel, MD⁷, Emma Groarke, MD^7*, Shawn M. Burgess, PhD^10*, Achim A Werner, PhD^11*, Ivona A Aksentijevich, MD^11*, Neal S. Young, MD⁷, Daniel L Kastner, MD PhD^12*, Peter C Grayson, MD^13* and Katherine Calvo, MD, PhD^14,15,16

¹Clinical center, building 10, Rm 2S245, National Institute of Health/National Cancer Institute, Bethesda, MD
²National Institute of Heath, Bethesda, DC
³Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD
⁴Inflammatory Disease Section, National Human Genome Research Institute, Bethesda, MD
⁵National Human Genome Research Institute, NIH, National Institutes of Health, Bethesda, MD
⁶National Institutes of Heath, Bethesda, DC
⁷Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
⁸National Institute of Heath, Bethesda, MD
⁹National Institutes of Health Clinical Center, Bethesda, MD
¹⁰NHGRI, NIH, Bethesda, MD
¹¹National Institutes of Heath, Bethesda, MD
¹²National Human Genome Research Institute, National Institutes of Heath, Bethesda, MD
¹³NIAMS/NIH, Bethesda
¹⁴Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD
¹⁵NIH Clinical Center, Bethesda, MD
¹⁶Hematology Section, Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD

Kiyomi Morita, MD, PhD¹, Guillermo Montalban Bravo, MD¹, Koji Sasaki, MD¹, Kristy R. Bodden^1*, Feng Wang, PhD^2*, Prithviraj Bose, MD¹, Yesid Alvarado, MD¹, Naval Daver, MD¹, Gautam Borthakur, MD¹, Farhad Ravandi, MBBS¹, Koichi Takahashi, MD, PhD¹, Elias Jabbour, MD¹, Courtney D. DiNardo, MD, MSc¹, Naveen Pemmaraju, MD¹, Tapan M. Kadia, MD¹, Maro Ohanian, DO^1*, Sherry A. Pierce, BSN, BA^1*, Mohammad Azab, MD, MSc, MBA^3*, Hagop M. Kantarjian, MD¹ and Guillermo Garcia-Manero, MD¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
³Astex Pharmaceuticals, Inc., Pleasanton, NJ

Kelly S. Chien, MD¹, Gautam Borthakur, MD², Kiran Naqvi, MD, MPH², Naval Daver, MD², Guillermo Montalban Bravo, MD², Jorge E. Cortes, MD², Courtney D. DiNardo, MD, MSc², Elias Jabbour, MD², Yesid Alvarado, MD³, Michael Andreeff, MD, PhD², Prithviraj Bose, MD², Nitin Jain, MD⁴, Kimberly Sheppard, BSN, RN^2*, Cheri Klingner-Winton^2*, Sherry A. Pierce, BSN, BA^2*, Xiao Qin Dong^2*, Kelly A. Soltysiak, PhD^1*, Hagop M. Kantarjian, MD² and Guillermo Garcia-Manero, MD²

¹Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁴Associate Professor of Medicine Department of Leukemia The University of Texas MD Anderson Cancer Center, Houston, TX

Rashmi Kanagal-Shamanna, MD¹, Guillermo Montalban Bravo, MD², Koji Sasaki, MD³, Carlos E. Bueso-Ramos, MD, PhD¹, Elias Jabbour, MD², Yue Wei, PhD², Faezeh Darbaniyan, PhD^4*, Mark Routbort, MD, PhD^1*, Sherry A. Pierce, BSN, BA^3*, Kelly A. Soltysiak, PhD^2*, Keyur Patel, MD, PhD^5*, L. Jeffrey Medeiros, MD¹, Hagop M. Kantarjian, MD² and Guillermo Garcia-Manero, MD³

¹Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX
⁵University of Texas MD Anderson Cancer Center, Houston, TX

Onyee Chan, MD, Najla Al Ali, MD^*, David A. Sallman, MD, Eric Padron, MD, Jeffrey E. Lancet, MD and Rami Komrokji, MD

Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL

Ahmad Nanaa^1*, Rama Nana^1*, Zhuoer Xie, MD¹, Dragan Jevremovic, MD, PhD^2*, Phuong L. Nguyen, MD², Cynthia Hengel^2*, Susan M. Geyer, PhD^3*, Rong He, MD², David S. Viswanatha, MD², Michael M. Timm^2*, Mohamed E Salama, MD², Min Shi, MD, PhD², Patricia Greipp, DO², Hassan B. Alkhateeb, MD^1*, William J Hogan, MB, BCh⁴, Mark Litzow, MD¹, Mrinal M. Patnaik, MD, MBBS¹, Mithun Vinod Shah, MD, PhD¹ and Aref Al-Kali, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
³Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN
⁴Mayo Clinic Rochester, Division of Hematology, Rochester, MN

John William Thomas^1*, Mithun Vinod Shah, MD, PhD², Pankit Vachhani, MD³, Omer Jamy, MD³, Ronald S. Go, MD² and Gaurav Goyal, MD⁴

¹Tinsley Harrison Internal Medicine Residency Program, University of Alabama at Birmingham, Birmingham, AL
²Division of Hematology, Mayo Clinic, Rochester, MN
³Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL
⁴University of Alabama at Birmingham, Birmingham, AL

Hitoshi Hanamoto^1*, Yasuyoshi Morita^2*, Motoshi Ichikawa^3*, Yasuhito Nannya, MD, PhD⁴, Hirohiko Shibayama, MD, PhD⁵, Yoshinobu Maeda, MD⁶, Tomoko Hata^7*, Toshihiro Miyamoto, MD, PhD⁸, Hiroshi Kawabata, MD, PhD⁹, Kazuto Takeuchi^10*, Hiroko Tanaka^11*, Junji Kishimoto^12*, Satoru Miyano, PhD^11*, Itaru Matsumura, MD, PhD¹³, Seishi Ogawa, MD, PhD¹⁴, Koichi Akashi, MD, PhD¹⁵, Yuzuru Kanakura, MD, PhD¹⁶ and Kinuko Mitani¹⁷

¹Department of Hematology, Nara Hospital, Kindai University, Ikoma City, Nara, Japan
²Department of Hematology and Rheumatology, Kindai University Hospital, Sakai, OSA, JPN
³Department of Hematology and Oncology, Dokkyo Medical University School of Medicine, Tochigi, Japan
⁴Department of Pathology and Tumor Biology, Kyoto University, Kyoto City, Japan
⁵Osaka University Hospital, Suita, Japan
⁶Department of Hematology and Oncology, Okayama University, Okayama, Japan
⁷Atomic Bomb Disease Institute Nagasaki, Nagasaki, JPN
⁸Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
⁹Dept. Hem/Immun, Kanazawa Medical University, Ishikawa, Japan
¹⁰First Department of Internal Medicine, Ehime University Hospital, Ehime, Japan
¹¹Department of Integrated Data Science, M&D Data Science Center, Tokyo Medical and Dental University, Tokyo, Japan
¹²Kyushu University Hospital, Fukuoka, JPN
¹³Faculty of Medicine Kinki University, Osaka-Sayama, Japan
¹⁴Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
¹⁵Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
¹⁶Sumitomo Hospital, Osaka, Japan
¹⁷Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan